Company Overview and News

1
B. Riley Financial's (RILY) CEO Bryant Riley on Q1 2018 Results - Earnings Call Transcript

2018-05-07 seekingalpha
B. Riley Financial, Inc. (NASDAQ:RILY) Q1 2018 Results Earnings Conference Call May 7, 2018 4:30 PM ET

 
Woolworth’s building to get a makeover

2018-04-24 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

1
Hudson's Bay Enters 2018 Seeking A Retail Turnaround

2018-04-05 seekingalpha
Hudson's Bay still has a huge amount of real estate value, but needs to halt the decline at some of its banners in order to be able to properly unlock that value.

 
How you can have $1 million by the time you’re 40 - MarketWatch

2018-03-31 marketwatch
It can feel like hitting the $1 million mark requires having a Wall Street job, a trust fund—or decades to save. But these millionaires may change your mind.

 
Ontario seniors to get $750 to help with home maintenance

2018-03-28 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Inside the Strange Odyssey of Hedge-Fund King Eddie Lampert | Vanity Fair

2018-03-26 vanityfair
Few people on Wall Street are as polarizing as Eddie Lampert, the billionaire majority shareholder of Sears and Kmart. His friends say he is reticent, while his critics find him aloof. His pals talk about his very high standards, while some observers say he is condescending, overly critical, and disengaged. Some people praise his determination and persistence, while others see only inexplicable stubbornness in sticking to failed ideas.

 
H&R Real Estate Investment Trust: This 6.8% Yielding REIT Is Trading At A Significant Discount

2018-03-22 seekingalpha
The company is currently trading at a significant discount to both its peers and to its own historical average.

 
Loblaw stumbles on Optimum-PC Points merger, bread rebate woes

2018-03-19 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Quinsam Appoints Keith Li as CFO

2018-03-19 globenewswire
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE

 
Court Orders Inquiry into Sears Canada Dividend Payment | Chief Investment Officer

2018-03-15 ai-cio
Canada’s Ontario Superior Court of Justice has appointed Toronto-based law firm Lax O’Sullivan Lisus Gottlieb as litigation investigator to review C$3 billion ($2.34 billion) in dividends paid out to Sears Canada’s shareholders, including Sears Holdings Corp. Chief Executive Edward Lampert.

 
A whole lot more than e-commerce to blame for declining malls

2018-03-11 cbc.ca
Malls were once a go-to shopping destination and a teenager's hangout of choice, but now face an uncertain future as some of their biggest tenants lay off employees, file for creditor protection or hang a "closed" sign in the window and leave for good.

 
Online shopping not the only factor behind Canada’s dying malls

2018-03-11 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

1
Sleep Country Canada Is Looking Good

2018-03-07 seekingalpha
The mattress retailer has several catalysts to potentially move its share price higher in the next year.

 
Court orders investigation of $3B Sears payout

2018-03-06 cbc.ca
Superior Court has appointed a litigation investigator to review $3 billion in payments made to Sears Canada shareholders, while the company's pension fund had a nearly $300 million shortfall.

 
Sears Canada shareholder payments to be reviewed

2018-03-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 81234D109